Kariv Tomer
SEC CIK 1568077 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Dir, 10% | 5,250 | — | — | 2 | 2022-11-29 | 2025-06-04 |
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
Kariv Tomer made no open-market trades at KROS in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-06 | 2025-06-04 | KROS | Keros Therapeutics, Inc. | Kariv Tomer | Dir, 10% | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| DMI | 2022-11-30 | 2022-11-29 | KROS | Keros Therapeutics, Inc. | Kariv Tomer | Dir, 10% | X - OptEx | $0.00 | -7,176 | 1.12M | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations